Andrew D Dickinson

Chief Financial Officer

Andrew D Dickinson (Chief Financial Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $463K of GILD (3,000 sh × $154.43, as filed), executed Feb 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 11 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.2M

shares × price, as filed

Last traded

Aug 17

Filed Aug 18

Median ADV $1.0B across their filed names

Open performance→

Volume by month

Buys $0 Sells $60.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names

GILD

Gilead Sciences, Inc. GILD · 0 buys · 25 sells 25 filings

Recent filings

GILDSALE Gilead Sciences, Inc. View filing → $415K
3,000 sh × $138.36
Exec Aug 17
Filed Aug 18 · 7:06 PM ET GILDSALE Gilead Sciences, Inc. View filing → $390K
3,000 sh × $129.93
Exec Jul 15
Filed Jul 16 · 6:08 PM ET GILDSALE Gilead Sciences, Inc. View filing → $376K
3,000 sh × $125.40
Exec Jun 15
Filed Jun 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $397K
3,000 sh × $132.27
Exec May 15
Filed May 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $423K
3,000 sh × $140.96
Exec Apr 15
Filed Apr 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $433K
3,000 sh × $144.23
Exec Mar 16
Filed Mar 17 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $463K
3,000 sh × $154.43
Exec Feb 17
Filed Feb 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $373K
3,000 sh × $124.31
Exec Jan 15
Filed Jan 16 · 5:30 PM ET More filings →